Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on <scp>SGLT2i</scp>: A Trajectories Analysis
We successfully identified three trajectory groups, with a substantial proportion of patients showing low use of drugs with NxP. Both social and clinical factors were associated with the use of NxP drugs.
Authors
- Sandra L. Kane‐Gill (ORCID: https://orcid.org/0000-0001-7523-4846)
- Levent Kirisci (ORCID: https://orcid.org/0000-0003-2786-3079)
- Inmaculada Hernandez (ORCID: https://orcid.org/0000-0002-0118-4986)
- Kerry M. Empey (ORCID: https://orcid.org/0000-0001-7531-2541)
- Nico Gabriel (ORCID: https://orcid.org/0000-0003-1793-2245)
- Jingchuan Guo (ORCID: https://orcid.org/0000-0001-9799-2592)
- Lanting Yang (ORCID: https://orcid.org/0000-0003-0597-9062)
- Kangho Suh (ORCID: https://orcid.org/0000-0002-7906-9398)
Institutions
- University of Pittsburgh (US)
- University of Florida (US)
- University of California San Diego (US)
- University of Montana (US)
- Florida College (US)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1002/pds.70098
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29